Cencora
Cencora, formerly known as the Alliance Healthcare Group, is a prominent player in the pharmaceutical distribution and logistics industry, headquartered in the United States. Founded in 2022, the company has rapidly established itself as a leader in providing innovative supply chain solutions across North America and Europe. Cencora specialises in a range of services, including pharmaceutical distribution, clinical trial logistics, and patient support programmes, setting itself apart with a commitment to efficiency and reliability. The company’s unique approach to integrating technology with traditional distribution methods has garnered recognition, positioning it as a trusted partner for healthcare providers and pharmaceutical manufacturers alike. With a focus on enhancing patient access to medications, Cencora continues to achieve significant milestones, reinforcing its status as a key player in the global healthcare landscape.
DitchCarbon Score
How does Cencora's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cencora's score of 12 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cencora's reported carbon emissions
In 2023, Cencora reported total greenhouse gas emissions of approximately 10,871,200 kg CO2e for Scope 1, about 87,492,000 kg CO2e for Scope 2 (market-based), and around 25,878,873,000 kg CO2e for Scope 3. This reflects a significant increase in emissions compared to 2019, when Scope 1 emissions were about 98,742,000 kg CO2e, Scope 2 emissions (market-based) were approximately 100,593,000 kg CO2e, and Scope 3 emissions totalled around 19,881,916,000 kg CO2e. Cencora has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 54.6% by FY2032, using FY2019 as the base year. Additionally, the company has pledged that 82% of its suppliers, based on spend, will have science-based targets by FY2027. These targets align with the necessary reductions to limit global warming to 1.5°C, demonstrating Cencora's commitment to addressing climate change within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2023 | |
|---|---|---|
| Scope 1 | 98,742,000 | 000,000,000 |
| Scope 2 | 100,593,000 | 00,000,000 |
| Scope 3 | 19,881,916,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cencora is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
